News

Please find the latest news about VivoSight listed below:

The posts can be filtered using the tabs above.

Optical Coherence Tomography: The first Quantitative Imaging Biomarker for Scleroderma

Skin Cancer Treatment without surgery: Cut-less Dermatology

Studies indicate that VivoSight OCT reliably predicts tumour margins

Dr Orit Markowitz at the IMCAS 2013 Annual Congress, Paris

International imaging meeting highlights growing importance of OCT in skin cancer treatment

EU Funded project to develop new lasers